Clinical trial
Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions…
NCT00458536 · Beth Israel Deaconess Medical Center, Other · Completed
Key facts
| NCT number | NCT00458536 |
|---|---|
| Title | Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF |
| Official title | Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF |
| Lead sponsor | Beth Israel Deaconess Medical Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH Dana-Farber Cancer Institute |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Renal Cancer |
| Intervention type | Biological, Drug |
| Interventions | Dendritic Cell Tumor Fusion Vaccine, Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) |
| Enrollment | 38 |
| Start date | Oct 1, 2004 |
| Primary completion | Dec 1, 2014 |
| Completion | Jul 1, 2023 |
| First posted | Apr 11, 2007 |
| Last update posted | Feb 9, 2026 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: